Moreover, the combination of these radiation therapies, followed with tumor-targeting immunocytokine therapy, had the best therapeutic effects, as evidenced by tumor cure, rejection of tumor rechallenge, and immunophenotyping indicating the dominant effector responses exerted by cytotoxic NK and CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.